Results 101 to 110 of about 728 (163)

Targeting p21 for diabetes: Another choice of senotherapy

open access: yesTargeting p21 for diabetes: Another choice of senotherapy
Senotherapy, the elimination of senescent cells, is a cutting-edge treatment for aging-related and lifestyle diseases. In this issue of Cell Metabolism, Wang et al. report that p21[Cip1] highly expressing cells, which represent a senescent cell population, occur in the adipose tissue during obesity.
openaire  

Is "cellular senescence" a misnomer? [PDF]

open access: yesGeroscience, 2022
Gems D, Kern CC.
europepmc   +1 more source

The Role of Renal Cell Senescence in Diabetic Kidney Disease: Mechanisms and Therapeutic Advances. [PDF]

open access: yesDiabetes Metab Syndr Obes
Yan Z   +7 more
europepmc   +1 more source

Senolytic Vaccines from the Central and Peripheral Tolerance Perspective. [PDF]

open access: yesVaccines (Basel)
Vasilieva MI   +6 more
europepmc   +1 more source

β-galactosidase-targeted senolytic prodrug ameliorates preclinical models of post-traumatic osteoarthritis. [PDF]

open access: yesEBioMedicine
Li Q   +10 more
europepmc   +1 more source

Prodrug nanoplatform for triggering ferroptosis to eliminate senescent cells in age-associated pathologies. [PDF]

open access: yesNat Commun
Jin C   +10 more
europepmc   +1 more source

Advances in Nanotherapy for Targeting Senescent Cells. [PDF]

open access: yesInt J Nanomedicine
Shi Y   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy